Clinical Trial Update: Maternal Buprenorphine-naloxone Treatment and the Infant [Phase 2]

View source ↗

Summary

Phase 2 trial update on maternal buprenorphine-naloxone treatment and infant outcomes related to maternal opioid use disorder and opioid exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Maternal Opioid Use Disorder
• Opioid Exposed Infant

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Johns Hopkins University | Conditions: Maternal Opioid Use Disorder, Opioid Exposed Infant | Phase 2 | Status: COMPLETED | Results posted: 2023-12-20